|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006405,
umls-concept:C0011209,
umls-concept:C0019682,
umls-concept:C0019699,
umls-concept:C0020811,
umls-concept:C0087111,
umls-concept:C0242456,
umls-concept:C0376196,
umls-concept:C0444454,
umls-concept:C0678257,
umls-concept:C1555721,
umls-concept:C1706204
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2007-8-10
|
|
pubmed:abstractText |
Injection drug use (IDU) accounts for 70 percent of HIV cases in Ukraine. Until buprenorphine maintenance therapy (BMT) was introduced, few effective strategies aimed at achieving reduction in illicit drug use were available as a conduit to anti-retroviral therapy (ARV) among IDUs.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1873-4758
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
18
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
326-8
|
|
pubmed:dateRevised |
2011-8-1
|
|
pubmed:meshHeading |
pubmed-meshheading:17689382-Adult,
pubmed-meshheading:17689382-Buprenorphine,
pubmed-meshheading:17689382-Female,
pubmed-meshheading:17689382-HIV Infections,
pubmed-meshheading:17689382-HIV Seropositivity,
pubmed-meshheading:17689382-HIV-1,
pubmed-meshheading:17689382-Health Services Accessibility,
pubmed-meshheading:17689382-Humans,
pubmed-meshheading:17689382-Male,
pubmed-meshheading:17689382-Narcotic Antagonists,
pubmed-meshheading:17689382-Needle-Exchange Programs,
pubmed-meshheading:17689382-Opioid-Related Disorders,
pubmed-meshheading:17689382-Pilot Projects,
pubmed-meshheading:17689382-Policy Making,
pubmed-meshheading:17689382-Program Development,
pubmed-meshheading:17689382-Substance Abuse, Intravenous,
pubmed-meshheading:17689382-Substance Abuse Treatment Centers,
pubmed-meshheading:17689382-Ukraine
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
HIV treatment access and scale-up for delivery of opiate substitution therapy with buprenorphine for IDUs in Ukraine--programme description and policy implications.
|
|
pubmed:affiliation |
Yale University AIDS Program, New Haven, CT 06510-2283, United States. robert.bruce@yale.edu <robert.bruce@yale.edu>
|
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|
